Oncolix
Pioneering new horizons in ovarian cancer treatment with a focus on autophagy through our innovative prolactin receptor antagonist.
0-1 employees · est. 2007
Oncolix is the older company (2011 vs 2007); Enterome is the larger of the two.
Side-by-Side Comparison
| Metric | Enterome | Oncolix |
|---|---|---|
| Founded | ||
| Founded | 2011 | 2007 older |
| Headquarters | ||
| Headquarters | Paris, France | Not tracked yet |
| Employees | ||
| Employees | 49 larger | 0-1 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $175.80M | $8.46M |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Development of off-the-shelf cancer immunotherapy treatments | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with B cell malignancies, Glioblastoma, adrenal tumors, and colorectal cancer | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Biopharmaceuticals, Drug Discovery, OncoMimics, Cancer Treatment, Immunomodulatory Drugs, Phase 2 Clinical Trials, Tumor Associated Antigens, CD8 T Cell Response, Glioblastoma, Adrenal Malignancies, Colorectal Cancer, Clinical-stage Biotech, Immunotherapies, Metagenomics | Clinical-stage, Cancer Treatment, Phase I Clinical Trial, Ovarian Cancer, Prolanta, Prolactin Receptor Antagonist, Autophagy, Oncology, Innovation |
| Website | ||
| Website | enterome.com | oncolixbio.com |
About Enterome
Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. The company's unique approach to d...
About Oncolix
Oncolix, a clinical-stage biotechnology company founded in 2007, is currently focused on pioneering new horizons in ovarian cancer treatment. The company's slogan emphasizes its commitment to innovation in this field, particularly through the development of an innovative prolactin receptor antagonis...
We will tell you when either one moves
BounceWatch watches Enterome and Oncolix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Enterome and Oncolix — by email.
Frequently Asked Questions
Compare Enterome with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Enterome on 7 Jun 2025, and Oncolix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.